🟢 Heron Therapeutics is trading 11% up on October 2, 2026, as jobs data eased rate-hike concerns

Heron Therapeutics is trading at $0.40, up 11.32%, with the move likely reflecting broader risk-on sentiment after softer-than-expected September jobs data eased rate-hike concerns.

• No new company-specific announcement was identified for October 2; Heron Therapeutics’ latest listed release is dated August 10.
• The S&P 500 and Nasdaq are both up more than 0.5% in the provided market context.